Shear wave elastography detects novel imaging biomarkers of aromatase inhibitor–induced joint pain: a pilot study

1. Bentzon N, During M, Rasmussen BB, Mouridsen H, Kroman N: Prognostic effect of estrogen receptor status across age in primary breast cancer. Int J Cancer 2008; 122: 1089–1094. Bentzon N During M Rasmussen BB Mouridsen H Kroman N : Prognostic effect of estrogen receptor status across age in primary breast cancer . Int J Cancer 2008 ; 122 : 1089 – 1094 . 10.1002/ijc.22892 Search in Google Scholar

2. Park SH, Knobf MT, Sutton KM: Etiology, assessment, and management of aromatase inhibitor-related musculoskeletal symptoms. Clin J Oncol Nurs 2012; 16: 260–266. Park SH Knobf MT Sutton KM : Etiology, assessment, and management of aromatase inhibitor-related musculoskeletal symptoms . Clin J Oncol Nurs 2012 ; 16 : 260 – 266 . 10.1188/12.CJON.260-266 Search in Google Scholar

3. Henry NL, Giles JT, Ang D, Mohan M, Dadabhoy D, Robarge J et al.: Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast Cancer Res Treat 2008; 111: 365–372. Henry NL Giles JT Ang D Mohan M Dadabhoy D Robarge J : Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors . Breast Cancer Res Treat 2008 ; 111 : 365 – 372 . 10.1007/s10549-007-9774-6 Search in Google Scholar

4. Crew KD, Greenlee H, Capodice J, Raptis G, Brafman L, Fuentes D et al.: Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer. J Clin Oncol 2007; 25: 3877–3883. Crew KD Greenlee H Capodice J Raptis G Brafman L Fuentes D : Prevalence of joint symptoms in postmenopausal women taking aromatase inhibitors for early-stage breast cancer . J Clin Oncol 2007 ; 25 : 3877 – 3883 . 10.1200/JCO.2007.10.7573 Search in Google Scholar

5. Zivian MT, Salgado B: Side Effects Revisited: Women’s Experiences with Aromatase Inhibitors. Breast Cancer Action, San Francisco 2008. Zivian MT Salgado B : Side Effects Revisited: Women’s Experiences with Aromatase Inhibitors . Breast Cancer Action , San Francisco 2008 . Search in Google Scholar

6. Howell A, Cuzick J, Baum M, Buzdar A, Dowsett M, Forbes JF et al.: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer. Lancet 2005; 365: 60–62. Howell A Cuzick J Baum M Buzdar A Dowsett M Forbes JF : Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years’ adjuvant treatment for breast cancer . Lancet 2005 ; 365 : 60 – 62 . 10.1016/S0140-6736(04)17666-6 Search in Google Scholar

7. Castel LD, Hartmann KE, Mayer IA, Saville BR, Alvarez J, Boomershine CS et al.: Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort. Cancer 2013; 119: 2375–2382. Castel LD Hartmann KE Mayer IA Saville BR Alvarez J Boomershine CS : Time course of arthralgia among women initiating aromatase inhibitor therapy and a postmenopausal comparison group in a prospective cohort . Cancer 2013 ; 119 : 2375 – 2382 . 10.1002/cncr.28016368700923575918 Search in Google Scholar

8. Murphy CC, Bartholomew LK, Carpentier MY, Bluethmann SM, Vernon SW: Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review. Breast Cancer Res Treat 2012; 134: 459–478. Murphy CC Bartholomew LK Carpentier MY Bluethmann SM Vernon SW : Adherence to adjuvant hormonal therapy among breast cancer survivors in clinical practice: a systematic review . Breast Cancer Res Treat 2012 ; 134 : 459 – 478 . 10.1007/s10549-012-2114-5360728622689091 Search in Google Scholar

9. Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A: Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 2008; 26: 556–562. Partridge AH LaFountain A Mayer E Taylor BS Winer E Asnis-Alibozek A : Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer . J Clin Oncol 2008 ; 26 : 556 – 562 . 10.1200/JCO.2007.11.545118180462 Search in Google Scholar

10. Makubate B, Donnan PT, Dewar JA, Thompson AM, McCowan C: Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality. Br J Cancer 2013; 108: 1515–1524. Makubate B Donnan PT Dewar JA Thompson AM McCowan C : Cohort study of adherence to adjuvant endocrine therapy, breast cancer recurrence and mortality . Br J Cancer 2013 ; 108 : 1515 – 1524 . 10.1038/bjc.2013.116362942723519057 Search in Google Scholar

11. Briot K, Tubiana-Hulin M, Bastit L, Kloos I, Roux C: Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study. Breast Cancer Res Treat 2010; 120: 127–134. Briot K Tubiana-Hulin M Bastit L Kloos I Roux C : Effect of a switch of aromatase inhibitors on musculoskeletal symptoms in postmenopausal women with hormone-receptor-positive breast cancer: the ATOLL (articular tolerance of letrozole) study . Breast Cancer Res Treat 2010 ; 120 : 127 – 134 . 10.1007/s10549-009-0692-720035381 Search in Google Scholar

12. Dizdar O, Ozcakar L, Malas FU, Harputluoglu H, Bulut N, Aksoy S et al.: Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia. J Clin Oncol 2009; 27: 4955–4960. Dizdar O Ozcakar L Malas FU Harputluoglu H Bulut N Aksoy S : Sonographic and electrodiagnostic evaluations in patients with aromatase inhibitor-related arthralgia . J Clin Oncol 2009 ; 27 : 4955 – 4960 . 10.1200/JCO.2008.20.5435 Search in Google Scholar

13. Morales L, Pans S, Paridaens R, Westhovens R, Timmerman D, Verhaeghe J et al.: Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging. Breast Cancer Res Treat 2007; 104: 87–91. Morales L Pans S Paridaens R Westhovens R Timmerman D Verhaeghe J : Debilitating musculoskeletal pain and stiffness with letrozole and exemestane: associated tenosynovial changes on magnetic resonance imaging . Breast Cancer Res Treat 2007 ; 104 : 87 – 91 . 10.1007/s10549-006-9394-6 Search in Google Scholar

14. Shanmugam VK, McCloskey J, Elston B, Allison SJ, Eng-Wong J: The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms. Breast Cancer Res Treat 2012; 131: 699–708. Shanmugam VK McCloskey J Elston B Allison SJ Eng-Wong J : The CIRAS study: a case control study to define the clinical, immunologic, and radiographic features of aromatase inhibitor-induced musculoskeletal symptoms . Breast Cancer Res Treat 2012 ; 131 : 699 – 708 . 10.1007/s10549-011-1849-8 Search in Google Scholar

15. Henry NL, Jacobson JA, Banerjee M, Hayden J, Smerage JB, Van Poznak C et al.: A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography. Cancer 2010; 116: 4360–4367. Henry NL Jacobson JA Banerjee M Hayden J Smerage JB Van Poznak C : A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography . Cancer 2010 ; 116 : 4360 – 4367 . 10.1002/cncr.25385 Search in Google Scholar

16. Morales L, Pans S, Verschueren K, Van Calster B, Paridaens R, Westhovens R et al.: Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome. J Clin Oncol 2008; 26: 3147–3152. Morales L Pans S Verschueren K Van Calster B Paridaens R Westhovens R : Prospective study to assess short-term intra-articular and tenosynovial changes in the aromatase inhibitor-associated arthralgia syndrome . J Clin Oncol 2008 ; 26 : 3147 – 3152 . 10.1200/JCO.2007.15.4005 Search in Google Scholar

17. Singer O, Cigler T, Moore AB, Levine AB, Hentel K, Belfi L et al.: Defining the aromatase inhibitor musculoskeletal syndrome: a prospective study. Arthritis Care Res (Hoboken) 2012; 64: 1910–1918. Singer O Cigler T Moore AB Levine AB Hentel K Belfi L : Defining the aromatase inhibitor musculoskeletal syndrome: a prospective study . Arthritis Care Res (Hoboken) 2012 ; 64 : 1910 – 1918 . 10.1002/acr.21756 Search in Google Scholar

18. Lintermans A, Laenen A, Van Calster B, Van Hoydonck M, Pans S, Verhaeghe J et al.: Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data. Ann Oncol 2013; 24: 350–355. Lintermans A Laenen A Van Calster B Van Hoydonck M Pans S Verhaeghe J : Prospective study to assess fluid accumulation and tenosynovial changes in the aromatase inhibitor-induced musculoskeletal syndrome: 2-year follow-up data . Ann Oncol 2013 ; 24 : 350 – 355 . 10.1093/annonc/mds290 Search in Google Scholar

19. Sarvazyan AP, Rudenko OV, Swanson SD, Fowlkes JB, Emelianov SY: Shear wave elasticity imaging: a new ultrasonic technology of medical diagnostics. Ultrasound Med Biol 1998; 24: 1419–1435. Sarvazyan AP Rudenko OV Swanson SD Fowlkes JB Emelianov SY : Shear wave elasticity imaging: a new ultrasonic technology of medical diagnostics . Ultrasound Med Biol 1998 ; 24 : 1419 – 1435 . 10.1016/S0301-5629(98)00110-0 Search in Google Scholar

20. Taljanovic MS, Gimber LH, Becker GW, Latt LD, Klauser AS, Melville DM et al.: Shear-wave elastography: basic physics and musculoskeletal applications. Radiographics 2017; 37: 855–870. Taljanovic MS Gimber LH Becker GW Latt LD Klauser AS Melville DM : Shear-wave elastography: basic physics and musculoskeletal applications . Radiographics 2017 ; 37 : 855 – 870 . 10.1148/rg.2017160116545288728493799 Search in Google Scholar

21. Burstein HJ, Lacchetti C, Anderson H, Buchholz TA, Davidson NE, Gelmon KA et al.: Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update. J Clin Oncol 2019; 37: 423–438. Burstein HJ Lacchetti C Anderson H Buchholz TA Davidson NE Gelmon KA : Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update . J Clin Oncol 2019 ; 37 : 423 – 438 . 10.1200/JCO.18.0116030452337 Search in Google Scholar

22. Dirrichs T, Quack V, Gatz M, Tingart M, Kuhl CK, Schrading S: Shear wave elastography (SWE) for the evaluation of patients with tendinopathies. Acad Radiol 2016; 23: 1204–1213. Dirrichs T Quack V Gatz M Tingart M Kuhl CK Schrading S : Shear wave elastography (SWE) for the evaluation of patients with tendinopathies . Acad Radiol 2016 ; 23 : 1204 – 1213 . 10.1016/j.acra.2016.05.01227318786 Search in Google Scholar

23. Ham S, Kim S, Choi H, Lee Y, Lee H: Greater muscle stiffness during contraction at menstruation as measured by shear-wave elastography. Tohoku J Exp Med 2020; 250: 207–213. Ham S Kim S Choi H Lee Y Lee H : Greater muscle stiffness during contraction at menstruation as measured by shear-wave elastography . Tohoku J Exp Med 2020 ; 250 : 207 – 213 . 10.1620/tjem.250.20732238619 Search in Google Scholar

24. Caprioli M, Carrara G, Sakellariou G, Silvagni E, Scire CA: Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology. RMD Open 2017; 3: e000523. Caprioli M Carrara G Sakellariou G Silvagni E Scire CA : Influence of aromatase inhibitors therapy on the occurrence of rheumatoid arthritis in women with breast cancer: results from a large population-based study of the Italian Society for Rheumatology . RMD Open 2017 ; 3 : 000523 . 10.1136/rmdopen-2017-000523564008929071118 Search in Google Scholar